These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10526190)

  • 1. A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials.
    Amato MP; Ponziani G; Bartolozzi ML; Siracusa G
    J Neurol Sci; 1999 Oct; 168(2):96-106. PubMed ID: 10526190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study on the prognosis of multiple sclerosis.
    Amato MP; Ponziani G
    Neurol Sci; 2000; 21(4 Suppl 2):S831-8. PubMed ID: 11205358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.
    Mandrioli J; Sola P; Bedin R; Gambini M; Merelli E
    J Neurol; 2008 Jul; 255(7):1023-31. PubMed ID: 18535872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.
    Eriksson M; Andersen O; Runmarker B
    Mult Scler; 2003 Jun; 9(3):260-74. PubMed ID: 12814173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events.
    Trojano M; Avolio C; Manzari C; Calò A; De Robertis F; Serio G; Livrea P
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):300-6. PubMed ID: 7897410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course and prognosis in early-onset MS: comparison with adult-onset forms.
    Simone IL; Carrara D; Tortorella C; Liguori M; Lepore V; Pellegrini F; Bellacosa A; Ceccarelli A; Pavone I; Livrea P
    Neurology; 2002 Dec; 59(12):1922-8. PubMed ID: 12499484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).
    Kantarci O; Siva A; Eraksoy M; Karabudak R; Sütlaş N; Ağaoğlu J; Turan F; Ozmenoğlu M; Toğrul E; Demirkiran M
    Neurology; 1998 Sep; 51(3):765-72. PubMed ID: 9748024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.
    Myhr KM; Riise T; Vedeler C; Nortvedt MW; Grønning R; Midgard R; Nyland HI
    Mult Scler; 2001 Feb; 7(1):59-65. PubMed ID: 11321195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
    Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
    Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.
    Becker M; Latarche C; Roman E; Debouverie M; Malaplate-Armand C; Guillemin F
    BMC Neurol; 2015 May; 15():79. PubMed ID: 25966681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of multiple sclerosis in Lebanon.
    Yamout B; Itani S; Arabi A; Hamzeh D; Yaghi S
    Int J Neurosci; 2010 Mar; 120(3):206-10. PubMed ID: 20374088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Course of illness and prognosis of multiple sclerosis. 2: Predictive value of clinical and paraclinical factors].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Jun; 67(6):444-51. PubMed ID: 8767198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for survival in multiple sclerosis.
    Lević ZM; Dujmović I; Pekmezović T; Jarebinski M; Marinković J; Stojsavljević N; Drulović J
    Mult Scler; 1999 Jun; 5(3):171-8. PubMed ID: 10408717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.
    Kremenchutzky M; Cottrell D; Rice G; Hader W; Baskerville J; Koopman W; Ebers GC
    Brain; 1999 Oct; 122 ( Pt 10)():1941-50. PubMed ID: 10506095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of multiple sclerosis in a population-based cohort.
    Debouverie M; Pittion-Vouyovitch S; Louis S; Guillemin F;
    Eur J Neurol; 2008 Sep; 15(9):916-21. PubMed ID: 18637953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
    Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
    Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.